1. Canadian evidence-based guideline for frontline treatment of chronic lymphocytic leukemia: 2022 update. (February 2023) Authors: Owen, Carolyn; Banerji, Versha; Johnson, Nathalie; Gerrie, Alina; Aw, Andrew; Chen, Christine; Robinson, Sue Journal: Leukemia research Issue: Volume 125(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison of outcomes among patients aged 80 and over and younger patients with diffuse large B-cell lymphoma: a population based study. Issue 3 (March 2014) Authors: Varga, Cindy; Holcroft, Christina; Kezouh, Abbas; Bucatel, Serghei; Johnson, Nathalie; Petrogiannis-Haliotis, Tina; Assouline, Sarit Journal: Leukemia & lymphoma Issue: Volume 55:Issue 3(2014:Mar.) Page Start: 533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Corrigendum to "Canadian evidence-based guideline for frontline treatment of chronic lymphocytic leukemia: 2022 update" [Leukemia Research 125 (2023) 107016]. (May 2023) Authors: Owen, Carolyn; Banerji, Versha; Johnson, Nathalie; Gerrie, Alina; Aw, Andrew; Chen, Christine; Robinson, Sue Journal: Leukemia research Issue: Volume 128(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Loss of HER2‐positivity following neoadjuvant targeted therapy for breast cancer is not associated with inferior oncologic outcomes. Issue 8 (20th August 2021) Authors: Wetzel, Catherine L.; Sutton, Thomas L.; Gardiner, Stuart; Farinola, Maryam; Johnson, Nathalie; Garreau, Jennifer R. Journal: Journal of surgical oncology Issue: Volume 124:Issue 8(2021) Page Start: 1224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The uracil-DNA glycosylase UNG protects the fitness of normal and cancer B cells expressing AID. (27th August 2020) Authors: Safavi, Shiva; Larouche, Ariane; Zahn, Astrid; Patenaude, Anne-Marie; Domanska, Diana; Dionne, Kiersten; Rognes, Torbjørn; Dingler, Felix; Kang, Seong-Kwi; Liu, Yan; Johnson, Nathalie; Hébert, Josée; Verdun, Ramiro E; Rada, Cristina A; Vega, Francisco; Nilsen, Hilde; Di Noia, Javier M Journal: NAR cancer Issue: Volume 2:Number 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The uracil–DNA glycosylase UNG protects the fitness of normal and cancer B cells expressing AID. Issue 1 (6th January 2021) Authors: Safavi, Shiva; Larouche, Ariane; Zahn, Astrid; Patenaude, Anne-Marie; Domanska, Diana; Dionne, Kiersten; Rognes, Torbjørn; Dingler, Felix; Kang, Seong-Kwi; Liu, Yan; Johnson, Nathalie; Hébert, Josée; Verdun, Ramiro E; Rada, Cristina A; Vega, Francisco; Nilsen, Hilde; Noia, Javier M D Journal: NAR cancer Issue: Volumer 3:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Time to surgery following neoadjuvant chemotherapy for breast cancer impacts residual cancer burden, recurrence, and survival. Issue 8 (30th October 2020) Authors: Sutton, Thomas L.; Schlitt, Alexander; Gardiner, Stuart K.; Johnson, Nathalie; Garreau, Jennifer R. Journal: Journal of surgical oncology Issue: Volume 122:Issue 8(2020) Page Start: 1761 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Use of minimal residual disease assessment in the treatment of chronic lymphocytic leukemia. Issue 12 (2nd December 2017) Authors: Owen, Carolyn; Christofides, Anna; Johnson, Nathalie; Lawrence, Tatiana; MacDonald, David; Ward, Carol Journal: Leukemia & lymphoma Issue: Volume 58:Issue 12(2017) Page Start: 2777 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗